Zu "1799711-21-9" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
dBET1
Artikelnummer: TGM-T4495-100mg
Description: dBET1 is a hybrid molecule that combines (+)-JQ1 and thalidomide. It induces cereblon-dependent BET protein degradation in vitro (EC50: 430 nM) and induces apoptosis. Target: Epigenetic Reader Domain, PROTACs. Smiles:...
| Anwendung: | Protac(R) reagent |
| CAS | 1799711-21-9 |
| MW: | 785.27 D |
ab 48,00 €
dBET1
Artikelnummer: Cay18044-1
dBET1 is a hybrid molecule that combines (+)-JQ1 (Cay-11187) and thalidomide (Cay-14610). The JQ1 portion facilitates binding of dBET1 to the bromodomains of BET family transcriptional activators. The thalidomide moiety drives proteasomal degradation, as phthalimides bind cereblon to create a substrate recognition...
| Schlagworte: | (6S)-4-(4-chlorophenyl)-N-[4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]but... |
| Anwendung: | Cereblon-dependent BET protein degradation |
| CAS | 1799711-21-9 |
| MW: | 785.3 D |
ab 61,00 €
dBET1
Artikelnummer: BPS-82021
dBET1 is a PROTAC compound comprised of BET bromodomain antagonist (+)-JQ1 linked to a cereblon E3 ubiquitin ligase ligand.
| Anwendung: | Protac(R) reagent |
| CAS | 1799711-21-9 |
| MW: | 785,3 D |
1.863,00 €
